Epigenetics in polycystic ovary syndrome: a pilot study of global DNA methylation
The percent global methylation of peripheral blood DNA was not significantly altered in 20 women with polycystic ovary syndrome (PCOS) compared with 20 controls. The study of specific tissues and target genomic regions will be required to further determine whether epigenetic alteration influences the development of PCOS.
Key Words: Epigenetics, DNA methylation, polycystic ovary syndrome
To access this article, please choose from the options below
N.X. has nothing to disclose. R.A. has nothing to disclose. M.O.G. has nothing to disclose.
This study was supported in part by National Institutes of Health grant nos. R01-HD29364 and K24-HD01346 (to RA), R01-DK79888 (to MOG), and M01-RR00425 (General Clinical Research Center Grant from the National Center for Research Resources [NCRR]); the Cedars-Sinai Winnick Clinical Scholars Award (to MOG) and an endowment from the Helping Hand of Los Angeles, Inc.
PII: S0015-0282(09)03882-5
doi:10.1016/j.fertnstert.2009.10.020
© 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

